Marcus Messenger

Marcus Messenger is an experienced professional in the pharmaceutical industry, currently serving as the Head of Business Development at Nxera Pharma since August 2020, after a significant tenure at Teva Pharmaceuticals where Marcus held multiple senior roles in global business development from October 2013 to August 2020. Previous experience includes positions at Proximagen Group plc as Senior Business Development Manager and Scientist, as well as roles at Eli Lilly & Co. Ltd and the Medical Research Council. Marcus holds a BSc from the University of Nottingham and a PhD from King's College London.